Cargando…
The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0
OBJECTIVE: The population representativeness of a clinical study is influenced by how real-world patients qualify for the study. We analyze the representativeness of eligible patients for multiple type 2 diabetes trials and the relationship between representativeness and other trial characteristics....
Autores principales: | Sen, Anando, Goldstein, Andrew, Chakrabarti, Shreya, Shang, Ning, Kang, Tian, Yaman, Anil, Ryan, Patrick B, Weng, Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378875/ https://www.ncbi.nlm.nih.gov/pubmed/29025047 http://dx.doi.org/10.1093/jamia/ocx091 |
Ejemplares similares
-
How Have Cancer Clinical Trial Eligibility Criteria Evolved Over Time?
por: Yaman, Anil, et al.
Publicado: (2016) -
Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials
por: Miotto, Riccardo, et al.
Publicado: (2015) -
Combining human and machine intelligence for clinical trial eligibility querying
por: Fang, Yilu, et al.
Publicado: (2022) -
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials
por: Kim, Jae Hyun, et al.
Publicado: (2020) -
VIBE 2.0: Visual Integration for Bayesian Evaluation
por: Beagley, Nathaniel, et al.
Publicado: (2010)